首页> 外文期刊>Experimental oncology >HELPER T CELLS (CD3~+/CD4~+) WITHIN THE AUTOLOGOUSPERIPHERAL BLOOD STEM CELL GRAFT POSITIVELY CORRELATEWITH EVENT FREE SURVIVAL OF MULTIPLE MYELOMA PATIENTS
【24h】

HELPER T CELLS (CD3~+/CD4~+) WITHIN THE AUTOLOGOUSPERIPHERAL BLOOD STEM CELL GRAFT POSITIVELY CORRELATEWITH EVENT FREE SURVIVAL OF MULTIPLE MYELOMA PATIENTS

机译:自体上皮血液干细胞移植物中的HELPER T细胞(CD3〜+ / CD4〜+)与多种骨髓炎患者的免费活动存活呈正相关

获取原文
获取原文并翻译 | 示例
       

摘要

High dose chemotherapy followed by autologousblood stem cell transplantation (ASCT) is standard treat-ment for younger patients with symptomatic multiplemyeloma (MM). The lymphocytes in the microenviron-ment of MM cells are an essential part of the patho-physiology of this incurable disease [1]. It has beenpreviously shown that lymphocytes within the graft arelinked to the survival of MM patients [2]. However, onlylittle is known which lymphocyte subsets are responsiblefor this tumor protective effect. In the presented studywe have analyzed the lymphocytes by immunopheno-typing in the peripheral blood (PB) and in the apheresisproduct (AP) of 41 consecutive patients.
机译:对于年轻的症状性多发性骨髓瘤(MM)患者,高剂量化疗后自体血干细胞移植(ASCT)是标准治疗方法。 MM细胞微环境中的淋巴细胞是这种无法治愈的疾病的病理生理学的重要组成部分[1]。以前已经表明,移植物中的淋巴细胞与MM患者的生存有关[2]。但是,几乎不知道哪些淋巴细胞亚群负责这种肿瘤保护作用。在本研究中,我们通过免疫表型分析对41例连续患者的外周血(PB)和单采产品(AP)进行了淋巴细胞分析。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号